Skip to main content

Table 2 Baseline and changes from baseline scores for Patient-Reported Outcomes by group

From: Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research

  Yoga Group (n = 27) Control Group (n = 21)  
   Mean (SD) Mean (SD) d a
NIH Patient Reported Outcomes Measurement Information System Outcomes Anxiety
 Baseline 54.0 (7.8) 50.2 (8.6)
 Change from baseline, wk. 7 −2.1 (5.0) −0.7 (5.4) − 0.27
 Change from baseline, wk. 12 −3.1 (5.7) −1.3 (7.1) −0.30
 Change from baseline, wk. 16 −4.2 (5.0) −2.0 (7.2) − 0.37
Depression
 Baseline 49.3 (7.9) 45.2 (6.0)
 Change from baseline, wk. 7 −3.7 (6.3) 0.3 (5.4) −0.64
 Change from baseline, wk. 12 −3.8 (5.4) 1.6 (7.7) − 0.78
 Change from baseline, wk. 16 −4.4 (7.0) −0.6 (7.1) −0.53
Interest Sexual Activity
 Baseline 43.0 (6.8) 43.8 (8.0)
 Change from baseline, wk. 7 −0.6 (5.8) − 0.2 (4.6) − 0.08
 Change from baseline, wk. 12 0.4 (4.9) 2.4 (4.2) −0.43
 Change from baseline, wk. 16 0.7 (5.0) −0.4 (6.9) 0.20
Mental Health
 Baseline 45.1 (5.1) 41.1 (5.0)
 Change from baseline, wk. 7 −5.0 (7.2) − 5.3 (5.0) 0.05
 Change from baseline, wk. 12 −5.1 (5.0) −4.8 (6.5) −0.05
 Change from baseline, wk. 16 −5.2 (4.2) −4.8 (5.0) −0.11
Orgasm
 Baseline 2.9 (1.9) 3.0 (1.6)
 Change from baseline, wk. 7 0.0 (1.6) 0.6 (1.6) −0.37
 Change from baseline, wk. 12 −0.2 (0.6) 0.1 (2.0) −0.16
 Change from baseline, wk. 16 −0.3 (0.8) 0.2 (1.9) −0.35
Pain Intensity
 Baseline 45.1 (8.6) 40.4 (9.0)
 Change from baseline, wk. 7 −1.6 (5.8) 0.6 (7.5) −0.34
 Change from baseline, wk. 12 −2.4 (7.0) 0.6 (6.6) −0.43
 Change from baseline, wk. 16 −3.2 (7.3) 0.8 (8.4) −0.51
Physical Health
 Baseline 39.8 (3.1) 40.0 (4.4)
 Change from baseline, wk. 7 −6.3 (6.2) −7.2 (6.8) 0.14
 Change from baseline, wk. 12 −6.6 (6.0) −3.5 (5.7) −0.52
 Change from baseline, wk. 16 −6.9 (7.3) −6.9 (6.9) 0.01
Satisfaction Sex Life
 Baseline 49.1 (12.6) 46.7 (12.8)
 Change from baseline, wk. 7 −1.0 (10.4) 2.4 (6.0) −0.38
 Change from baseline, wk. 12 −0.9 (6.6) 2.9 (12.6) −0.41
 Change from baseline, wk. 16 −1.7 (8.2) −0.3 (11.4) −0.15
Vaginal Discomfort
 Baseline 48.0 (5.9) 48.0 (4.3)
 Change from baseline, wk. 7 0.7 (4.0) −1.5 (3.8) 0.55
 Change from baseline, wk. 12 0.5 (4.1) −1.5 (5.6) 0.43
 Change from baseline, wk. 16 −0.8 (3.2) −2.3 (1.7) 0.51
Sleep
 Baseline 50.1 (6.2) 48.8 (6.7)
 Change from baseline, wk. 7 −2.3 (5.8) 0.2 (5.2) −0.44
 Change from baseline, wk. 12 −2.5 (5.9) 1.0 (4.7) −0.61
 Change from baseline, wk. 16 −3.8 (7.6) −2.1 (5.0) −0.26
Quality of Life
 Baseline (1–5) 3.1 (0.8) 2.6 (0.9)
 Change from baseline, wk. 7 −0.4 (0.6) −0.4 (0.8) 0.10
 Change from baseline, wk. 12 −0.1 (0.5) −0.3 (0.9) 0.34
 Change from baseline, wk. 16 −0.2 (0.5) −0.3 (0.9) 0.09
MPN Symptom Assessment Form Outcomes Fatigue
 Baseline (0–10) 5.4 (2.3) 4.5 (2.8)
 Change from baseline, wk. 7 −0.7 (2.5) −0.8 (3.1) 0.02
 Change from baseline, wk. 12 −0.5 (2.2) −0.6 (2.3) 0.06
 Change from baseline, wk. 16 −0.7 (2.4) 0.6 (2.0) −0.56
Total Symptom Score
 Baseline (0–100) 28.7 (15.6) 21.9 (13.5)
 Change from baseline, wk. 7 −1.4 (9.5) −5.8 (11.2) 0.44
 Change from baseline, wk. 12 −2.7 (8.5) −4.1 (9.5) 0.15
 Change from baseline, wk. 16 4.4 (8.8) 7.1 (8.7) −0.31
  1. Note: lower scores represent an improvement for each measured outcome. NIH PROMIS outcomes are converted to standardized t-scores
  2. acohen’s d was used for effect sizes